MESO vs ROIV
Mesoblast Limited · Roivant Sciences Ltd.
Relative return (rebased to 100)
Key stats
| Metric | MESO | ROIV |
|---|---|---|
| Price | $14.29 | $35.44 |
| Market Cap | $18.53B | $25.60B |
| P/E | — | — |
| P/B | 32.25 | 6.05 |
| P/S | 1077.58 | 3099.17 |
| ROE | -17.8% | -7.1% |
| Net Margin | -593.9% | -3629.2% |
| Gross Margin | — | — |
| Revenue Growth | 191.4% | -71.6% |
| Dividend Yield | — | — |
| EPS | -$0.08 | -$0.42 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.